Dr. Hans Hammers, M.D., Ph.D., is Vice President of the KCCure Board of Directors and a renowned physician and researcher of renal cell carcinoma. Dr. Hammers’s work in immunotherapy has been nationally recognized, and he has been the principal investigators on several industry and investigator sponsored trials.
In June 2016, Dr. Hammers joined the faculty at UT Southwestern, where he is Associate Professor in the Department of Internal Medicine and Co-Leader of Clinical Research and Immunotherapy of the Kidney Cancer Program. His research interest is in developing novel immunotherapies for kidney cancer. Before joining UT Southwestern, Dr. Hammers led the kidney cancer research efforts at Johns Hopkins.
Dr. Hammers earned degrees from the University of Lubeck in Germany. He completed his residency training in the Johns Hopkins medical system and completed his fellowship in Medical Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital. He is the inaugural recipient of the Eugene P. Frenkel Scholar Award at UT Southwestern